Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.

Puri D, Bhandari A, Gaur PK, Yasir M, Kumar SS, Choudhary D, Saxena PK.

Curr Clin Pharmacol. 2018;13(2):128-135. doi: 10.2174/1574884713666180309153942.

PMID:
29521214
2.

New Drugs and Vaccines for Tuberculosis.

Gaur PK, Mishra S.

Recent Pat Antiinfect Drug Discov. 2017;12(2):147-161. doi: 10.2174/1574891X12666171006105921. Review.

PMID:
28990539
3.

Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.

Yasir M, Gaur PK, Puri D, Shehkar P, Kumar SS.

Curr Drug Deliv. 2018;15(6):818-828. doi: 10.2174/1567201814666170525121049.

PMID:
28545354
4.

An Overview on Bacteriophages: A Natural Nanostructured Antibacterial Agent.

Rastogi V, Pragya, Verma N, Mishra AK, Nath G, Gaur PK, Verma A.

Curr Drug Deliv. 2018;15(1):3-20. doi: 10.2174/1567201813666160406115744. Review.

PMID:
27048165
5.

Formulation and evaluation of controlled-release of telmisartan microspheres: In vitro/in vivo study.

Gaur PK, Mishra S, Bajpai M.

J Food Drug Anal. 2014 Dec;22(4):542-548. doi: 10.1016/j.jfda.2014.05.001. Epub 2014 Aug 8.

6.

Development of ibuprofen nanoliposome for transdermal delivery: Physical characterization, in vitro/in vivo studies, and anti-inflammatory activity.

Gaur PK, Bajpai M, Mishra S, Verma A.

Artif Cells Nanomed Biotechnol. 2016;44(1):370-5. doi: 10.3109/21691401.2014.953631. Epub 2014 Sep 11.

PMID:
25211229
7.

Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies.

Gaur PK, Mishra S, Bajpai M, Mishra A.

Biomed Res Int. 2014;2014:363404. doi: 10.1155/2014/363404. Epub 2014 May 21.

8.

Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn.

Mishra S, Aeri V, Gaur PK, Jachak SM.

Biomed Res Int. 2014;2014:808302. doi: 10.1155/2014/808302. Epub 2014 May 14. Review.

9.

Formulation and evaluation of guggul lipid nanovesicles for transdermal delivery of aceclofenac.

Gaur PK, Mishra S, Aeri V.

ScientificWorldJournal. 2014 Feb 6;2014:534210. doi: 10.1155/2014/534210. eCollection 2014.

10.

Solid lipid nanoparticles of guggul lipid as drug carrier for transdermal drug delivery.

Gaur PK, Mishra S, Purohit S.

Biomed Res Int. 2013;2013:750690. doi: 10.1155/2013/750690. Epub 2013 Aug 24.

11.

Development of aceclofenac nanovesicular system using biomaterial for transdermal delivery: physical characterization, ex vivo, in vivo, and anti-inflammatory studies.

Gaur PK, Purohit S, Mishra S.

J Biomater Sci Polym Ed. 2013;24(18):2126-41. doi: 10.1080/09205063.2013.828579. Epub 2013 Aug 14.

PMID:
23944964
12.

Development of a new nanovesicle formulation as transdermal carrier: formulation, physicochemical characterization, permeation studies and anti-inflammatory activity.

Gaur PK, Mishra S, Purohit S, Kumar Y, Bhandari A.

Artif Cells Nanomed Biotechnol. 2014 Oct;42(5):323-30. doi: 10.3109/21691401.2013.827119. Epub 2013 Aug 15.

PMID:
23944163
13.

Development and characterization of stable nanovesicular carrier for drug delivery.

Gaur PK, Purohit S, Kumar Y, Mishra S, Bhandari A.

Artif Cells Nanomed Biotechnol. 2014 Oct;42(5):296-301. doi: 10.3109/21691401.2013.818009. Epub 2013 Jul 19.

PMID:
23865793
14.

Development and optimization of gastroretentive mucoadhesive microspheres of gabapentin by Box-Behnken design.

Gaur PK, Mishra S, Kumar A, Panda BP.

Artif Cells Nanomed Biotechnol. 2014 Jun;42(3):167-77. doi: 10.3109/21691401.2013.800081. Epub 2013 Jun 13.

PMID:
23763514
15.

Ceramide-2 nanovesicles for effective transdermal delivery: development, characterization and pharmacokinetic evaluation.

Gaur PK, Purohit S, Kumar Y, Mishra S, Bhandari A.

Drug Dev Ind Pharm. 2014 Apr;40(4):568-76. doi: 10.3109/03639045.2013.782502. Epub 2013 Apr 3.

PMID:
23547761
16.

Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery.

Gaur PK, Purohit S, Kumar Y, Mishra S, Bhandari A.

Pharm Dev Technol. 2014 Feb;19(1):48-54. doi: 10.3109/10837450.2012.751406. Epub 2013 Jan 2.

PMID:
23281714
17.

Targeted drug delivery of Rifampicin to the lungs: formulation, characterization, and stability studies of preformed aerosolized liposome and in situ formed aerosolized liposome.

Gaur PK, Mishra S, Gupta VB, Rathod MS, Purohit S, Savla BA.

Drug Dev Ind Pharm. 2010 Jun;36(6):638-46. doi: 10.3109/03639040903410300.

PMID:
20136485
18.

In-situ formation of liposome of rifampicin: better availability for better treatment.

Gaur PK, Mishra S, Gupta VB, Rathod MS, Purohit S, Savla BA.

Curr Drug Deliv. 2009 Oct;6(5):461-8.

PMID:
19751202
19.

A new biomarker in monitoring breast cancer: CA 549.

Beveridge RA, Chan DW, Bruzek D, Damron D, Bray KR, Gaur PK, Ettinger DS, Rock RC, Shurbaji MS, Kuhajda FP.

J Clin Oncol. 1988 Dec;6(12):1815-21.

PMID:
3058875
20.

Monitoring breast cancer with CA 549.

Chan DW, Beveridge RA, Bruzek DJ, Damron DJ, Bray KR, Gaur PK, Ettinger DS, Rock RC.

Clin Chem. 1988 Oct;34(10):2000-4.

21.
22.
23.

Immunocytochemical characterization of a monoclonal antibody that recognizes mitosing cells.

Lloyd RV, Wilson BS, Varani J, Gaur PK, Moline S, Makari JG.

Am J Pathol. 1985 Nov;121(2):275-83.

24.

Immunosorbent chromatography of sea nettle (Chrysaora quinquecirrha) venom and characterization of toxins.

Cobbs CS, Gaur PK, Russo AJ, Warnick JE, Calton GJ, Burnett JW.

Toxicon. 1983;21(3):385-91.

PMID:
6137883
25.
26.

Production of a monoclonal antibody against the sea nettle venom mouse lethal factor.

Gaur PK, Anthony RL, Cody TS, Calton GJ, Burnett JW.

Proc Soc Exp Biol Med. 1981 Jul;167(3):374-7. No abstract available.

PMID:
6114492
27.

Production and characterization of aflatoxin B2a antiserum.

Gaur PK, Lau HP, Pestka JJ, Chu FS.

Appl Environ Microbiol. 1981 Feb;41(2):478-82.

28.

Enzyme-linked immunosorbent assay to detect anti-sea nettle venom antibodies.

Gaur PK, Calton GJ, Burnett JW.

Experientia. 1981;37(9):1005-7. No abstract available.

PMID:
6117473
29.

Quantitation of aflatoxin B1 and aflatoxin B1 antibody by an enzyme-linked immunosorbent microassay.

Pestka JJ, Gaur PK, Chu FS.

Appl Environ Microbiol. 1980 Dec;40(6):1027-31.

30.

Comparison of antibody production against aflatoxin B1 in goats and rabbits.

Gaur PK, El-Nakib O, Chu FS.

Appl Environ Microbiol. 1980 Sep;40(3):678-80.

31.

Comparative study of a new Chrysosporium species with Histoplasma capsulatum.

Gaur PK, Lichtwardt RW.

Sabouraudia. 1980 Jun;18(2):105-14.

PMID:
6158762
32.

Mating types and convertibility among soil isolates of Histoplasma capsulatum.

Gaur PK, Lichtwardt RW.

Mycologia. 1980 Mar-Apr;72(2):404-6. No abstract available.

PMID:
7383051
33.

Preliminary visual screening of soil samples for the presumptive presence of Histoplasma capsulatum.

Gaur PK, Lichtwardt RW.

Mycologia. 1980 Mar-Apr;72(2):259-69. No abstract available.

PMID:
6991935

Supplemental Content

Support Center